Increased Mortality Among Lean Versus Non-Lean Adults With MASLD: A Multicenter Study.

Leith Ghani1, Majd B Aboona1, Claire S Faulkner2

  • 1Department of Internal Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA.

Summary

Lean individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) face higher mortality and cardiovascular risks. This study highlights the urgent need for targeted interventions and further research into this often-overlooked patient group.